Identification of a renal-specific oxido-reductase in
newborn diabetic mice
Qiwei Yang*, Bharat Dixit, Jun Wada*, Yufeng Tian*, Elisabeth I. Wallner*, Satish K. Srivastva,
and Yashpal S. Kanwar*
*Department of Pathology, Northwestern University Medical School, Chicago, IL 60611; and Department of Biochemistry, University of Texas Medical
Branch, Galveston, TX 77555
Communicated by Emanuel Margoliash, University of Illinois, Chicago, IL, June 8, 2000 (received for review February 23, 2000)
generated from sorbitol because the synthesis of these ECM
Aldose reductase (ALR2), a NADPH-dependent aldo-keto reductase
proteins can be normalized by the use of an ALR2 inhibitor,
(AKR), is widely distributed in mammalian tissues and has been
sorbinil (8, 9). The linkage of these two pathways also is
implicated in complications of diabetes, including diabetic ne-
supported by studies that showed ALR2 to have a high substrate
phropathy. To identify a renal-speci c reductase belonging to the
affinity for glycated methylglyoxal (10). Because of the original
AKR family, representational difference analyses of cDNA from
description of ALR2, a number of aldo-keto reductase (AKR)
diabetic mouse kidney were performed. A full-length cDNA with an
family members have been discovered in various mammalian
ORF of 855 nt and yielding a 1.5-kb mRNA transcript was isolated
tissues (11). So far, among this superfamily, there is no known
from a mouse kidney library. Human and rat homologues also were
renal-specific reductase that has been described and can be
isolated, and they had 91% and 97% amino acid identity with
linked to hyperglycemia in diabetes mellitus. In view of the above
mouse protein. In vitro translation of the cDNA yielded a protein
considerations, we initiated studies to search for such a reduc-
product of 33 kDa. Northern and Western blot analyses, using the
tase, using representational difference analysis (RDA) of cDNA
cDNA and antirecombinant protein antibody, revealed its expres-
(12), in the kidneys of streptozotocin-induced diabetes in new-
sion exclusively con ned to the kidney. Like ALR2, the expression
born mice. A number of cDNA fragments were isolated that had
was up-regulated in diabetic kidneys. Its mRNA and protein ex-
up-regulated mRNA expression. In this communication, we
pression was restricted to renal proximal tubules. The gene neither
describe the identification of a kidney-specific oxido-reductase
codistributed with Tamm Horsfall protein nor aquaporin-2. The
that is up-regulated in the hyperglycemic state.
deduced protein sequence revealed an AKR-3 motif located near
the N terminus, unlike the other AKR family members where it is
Materials and Methods
con ned to the C terminus. Fluorescence quenching and reactive
Induction of Diabetes in Newborn Mice. Hyperglycemic state was
blue agarose chromatography studies revealed that it binds to
induced in ICR newborn mice (Harlan) by an i.p. injection of
NADPH with high af nity (KdNADPH 66.9 2.3 nM). This binding
streptozotocin (200 mg kg of weight) in citrate buffer. Control
domain is a tetrapeptide (Met-Ala-Lys-Ser) located within the
mice received buffer only. After 3 weeks, kidneys of mice with
AKR-3 motif that is similar to the other AKR members. The iden-
blood glucose levels 250 mg dl were harvested and snap-
ti ed protein is designated as RSOR because it is renal-speci c with
frozen in liquid nitrogen, and total RNA was extracted.
properties of an oxido-reductase, and like ALR2 it may be relevant
in the renal complications of diabetes mellitus.
RDA. The method of cDNA-RDA was used to isolate glucose-
induced genes in the kidneys of diabetic mice (DM) (12). Briefly,
diabetes mellitus diabetic nephropathy
total RNA from normal mouse (NM) and DM kidneys was
isolated, poly(A) RNA was selected, and first- and second-
R enal complications are a common manifestation of diabetes
strand cDNAs were synthesized. The double-stranded cDNAs
mellitus. Characteristics of these complications are an in-
were subjected to subtractive hybridization, where the NM
crease of extracellular matrix (ECM) proteins, i.e., type I and
kidney cDNA was used as the driver and that of the DM kidney
type IV collagens and decorin and fibronectin, synthesized by
as the tester. After three rounds of subtractive hybridization, the
glomerular, tubular, and interstitial cells (1). The increase in
difference products (DPs) were isolated and analyzed by 2%
ECM may be multifactorial, but recent studies have narrowed it
agarose gel electrophoresis. After removal of the linkers by
down to two or three pathogenetic mechanisms that are affected
digestion with DpnII, they were ligated into BamHI-digested
by hyperglycemia. The hyperglycemia may increase the mRNA
pBluescript KS (Stratagene). After transformation, bacterial
expression and bioactivity of certain cytokines that modulate the
colonies were picked to prepare plasmid DNAs for nucleotide
synthesis of various ECM proteins, e.g., transforming growth
sequencing. The sequence of various DPs was subjected to
factor (2, 3). Nonenzymatic glycation is another mechanism by
homology search by the BLAST program via the National Center
which various Amadori intermediaries lead to the generation of
advanced glycation products (AGEs). The AGEs further cross-
link the glycated proteins with one another and render them
Abbreviations: AGE, advanced glycation product; AKR, aldo-keto reductase; ALR1, alde-
extremely resistant to proteolytic degradation, resulting in an hyde reductase; ALR2, aldose reductase; DM, diabetic mouse; DP, difference product; ECM,
accumulation of ECM in the kidney (4). Such an AGE-mediated extracellular matrix; NC, nitrocellulose; NM, normal mouse; RBG, reactive blue agarose;
cross-linking process is not restricted to the kidney tissue pro- RDA, representational difference analysis; RSOR, renal-speci c oxido-reductase.
teins alone, but it affects other tissue proteins as well, e.g., ocular Data deposition: The sequences reported in this paper have been deposited in the GenBank
lens crystallins (5, 6). Another mechanism that is also relevant database (accession nos. AF197127, AF197128, and AF197129).
to diabetic nephropathy is the polyol pathway, which consists of To whom reprint requests should be addressed at: Department of Pathology, Northwest-
two major reactions. First, glucose is reduced by aldose reduc- ern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611. E-mail:
*-******@***.***.
tase (ALR2) to sorbitol by using NADPH as the hydrogen donor.
The publication costs of this article were defrayed in part by page charge payment. This
The sorbitol then is oxidized by sorbitol dehydrogenase to article must therefore be hereby marked advertisement in accordance with 18 U.S.C.
fructose by using NAD as the hydrogen acceptor (7). Conceiv- 1734 solely to indicate this fact.
ably, there is a link between the polyol pathway and the glycation Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073 pnas.160266197.
of collagens and fibronectin by excessive amounts of fructose Article and publication date are at www.pnas.org cgi doi 10.1073 pnas.160266197
9896 9901 PNAS August 29, 2000 vol. 97 no. 18
for Biotechnology Information on-line service. The DNA frag- Expression of fusion proteins was induced by the addition of 1
ments of the DPs that were novel and differentially regulated and mM isopropyl-1-thio- -D-galactopyranoside in the medium, and
had definitive mRNA transcripts by Northern blot analysis were the culture was extended for another 3 h. The cells were
further investigated. harvested by centrifugation at 5,000 g, and the pellet was
resuspended in an ice-cold binding buffer (5 mM imidazole 0.5
M NaCl 20 mM Tris HCl, pH 7.9) and sonicated, and then the
cDNA Library Screening, Isolation of Full-Length cDNA, and Nucleotide
Sequencing. A DP with 130 bp that yielded mRNA transcript of lysate was centrifuged at 39,000 g. The supernatant was loaded
1.5 kb was further characterized and was used for screening a onto a nickel-charged column. The column was successively
mouse kidney library (13). Nitrocellulose (NC) filter lifts were washed with the binding buffer and a washing buffer (60 mM
made, prehybridized, and hybridized with the radiolabeled imidazole 0.5 M NaCl 20 mM Tris Cl, pH 7.9). The bound
screening probe. The cDNA clones with overlapping sequences proteins were eluted with an elution buffer (1 M imidazole 0.5
were isolated and subcloned into pBluescript II KS (Strat- M NaCl 20 mM Tris Cl, pH 7.9). The fractions with high
agene), and nucleotide sequencing, homology, and protein content of proteins were pooled and dialyzed against 0.1 M PBS
structural analyses were performed. Rat and human kidney and deionized water. The purity of the isolated fusion protein
cDNA libraries (Stratagene) were screened to isolate mouse was assessed by SDS PAGE analysis.
homologues.
Generation and Characterization of the Antibody. The fusion protein
Northern and Southern Blot Analyses. For Northern analyses, 30 g was used for raising polyclonal antibody in rabbits (14). For
of total RNAs extracted from NM and DM kidneys was glyoxy- Western blot analyses, protein lysates were prepared by homog-
lated, subjected to 1% agarose gel electrophoresis, and capillary- enizing various mouse tissues in ice-cold extraction buffer (10
transferred to nylon membranes. The membrane blots were mM Hepes 1.5 mM MgCl2 10 mM KCl 0.5 mM DTT 1 mM
hybridized with -32P-dCTP-labeled full-length human or mouse PMSF, pH 7.4). The nuclei were pelleted by centrifuging the
cDNA as isolated above. The blots were washed and hybridized homogenate at 3,000 g at 4 C. The concentration of the protein
under high stringency conditions, and autoradiograms were in the supernatant was adjusted to 20 mg ml, followed by 10%
prepared (13). In addition, RNAs isolated from various mouse SDS PAGE under reducing conditions. The gel proteins were
tissues and kidneys of rat and human were processed for electroblotted onto a NC membrane (14). The membrane blot
Northern blot analyses. For Southern blot analyses, kidney was immersed in a blocking solution containing 5% nonfat milk
tissues from adult mouse, rat, and human were obtained, and and Triton X-100 TBS (0.5% Triton X-100 0.1 M Tris 0.15 M
genomic DNA was isolated (14). The DNA (10 g) was subjected NaCl, pH 7.5). This was followed by successive incubations, 60
to a 0.8% agarose gel electrophoresis after digestion with various min each, with the polyclonal antifusion protein antibody (1:100
restriction endonucleases, which included EcoRI, XbaI, PstI, dilution) and anti-rabbit IgG conjugated with horseradish per-
BamHI, HindIII, and SalI. The gels were treated with 0.2 M HCl, oxidase (1:1,000 dilution) at 37 C. The blot was washed three
BIOCHEMISTRY
followed by successive treatments with denaturing and neutral- times with Triton X-100 TBS and immersed in a chemilumines-
izing solutions (14). Duplicate blots were prepared by transfer- cent reagent solution (Bio-Rad), and autoradiograms were
ring the digested DNAs onto nylon membranes. The blots developed. The analyses also were carried out on blots with the
were hybridized either with the -32P-dCTP-radiolabeled 5 intact fusion protein and another aliquot that had been absorbed
end-specific or 3 end-specific probes under high stringency with the antibody.
conditions.
Tissue Expression Studies. For in situ hybridization studies, the
In Vitro Translation Studies. The studies were performed to con- full-length cDNA clone was selected as a template to generate
-33P-UTP-labeled sense and antisense riboprobes by using the
firm the ORF of the mouse cDNA clones and to verify the size
of the putative protein product. Two full-length cDNAs were Riboprobe in vitro Transcription System (Promega). The ribo-
selected as the template. They were subcloned into pCR2.1 probes then were used for in situ hybridization with the mouse
vector (Invitrogen) by using PCR and sense (5 -CATGTCTT- kidney sections (13). For protein expression, 4- m-thick cryostat
TCATTCTTTATTGATACCCAGC-3 ) and antisense (5 - kidney sections were prepared, incubated with the polyclonal
TTGCTCCCTCAGGATGAAGG-3 ) primers. A TNT-coupled antifusion protein antibody, and reincubated with goat anti-
reticulocyte lysate in vitro translation system was used (Pro- rabbit IgG antibody conjugated with FISH, and then examined
mega), and the translation was carried out in the presence of with an UV light microscope. To delineate a definitive spatial
[35S]methionine and T7 RNA polymerase. The reaction products distribution of the fusion protein in the kidney, its expression
were subjected to 10% SDS PAGE, and autoradiograms were relative to other tubular proteins, i.e., Tamm Horsfall protein
prepared. A positive control included luciferase-encoding plas- and aquaporin-2, was investigated. Tamm Horsfall and aqua-
mid that yields a translated product of 61 kDa. porin-2 are markers of distal tubular and collecting duct epithe-
lia, respectively (15, 16). Serial cryostat tissue sections were
Isolation of the Fusion Protein. Two expression constructs were prepared and stained either with anti-Tamm Horsfall (ICN) and
generated by PCR using full-length cDNA isolated from the antifusion protein or antiaquaporin-2 (a gift from Mark Knep-
mouse kidney library. A XhoI site (CTCGAG) was introduced by per, National Institutes of Health, Bethesda, MD) and antifusion
using sense primer 5 -GGGGGGCTCGAGATGAAGGTC- protein. The sections then were stained with secondary antibod-
GATGTGG-3 and antisense primer 5 -GGGGGGCTCGAGT- ies that were conjugated with fluorescein or rhodamine and
CACCAGCTCAGGGTGCCG-3 . Flanking GC clamps examined.
(GGGGGG) also were included into the primer sequences. The
PCR-amplified products were digested with XhoI, agarose gel- Characterization of the Fusion Protein. Initially, immunologic cross-
purified, and ligated into the XhoI-digested pET-15b vector reactivity of the fusion protein with other enzyme proteins
carrying an N-terminal His Tag sequence (Novagen). The con- [aldehyde reductase (ALR1) and ALR2] that may be involved in
structs were sequenced to ensure proper in-frame ligation, Taq hyperglycemic state was investigated by dot blot method. One
polymerase fidelity, and their 5 and 3 end orientation. Trans- microgram of recombinant ALR1 or ALR2 (17, 18) was applied
formation was performed by using bacterial host BL21(DE3) onto a NC paper and air-dried. After blocking with 5% fat-free
(Novagen). A single colony was picked, and the bacteria were milk solution, the NC paper was incubated with antifusion
allowed to grow in LB medium until an A600 of 0.6 was achieved. protein antibody. The NC paper was washed with PBS contain-
Yang et al. PNAS August 29, 2000 vol. 97 no. 18 9897
ing 0.5% Tween 20 and incubated with goat anti-rabbit IgG
conjugated with alkaline phosphatase. The NC paper was re-
washed, and color development was performed by using AP kit
(Bio-Rad). BSA was used as a negative control. A mild reactivity
of the antibody with the AKR suggested that the isolated fusion
protein might belong to the family of AKRs that contain
NADPH-binding domain(s). This led us to investigate its affinity
characteristics for NADPH by fluorescence spectrophotometry.
All fluorescence titrations were performed at 25 C in 50 mM
potassium phosphate, pH 7.0 by using an excitation wavelength
of 280 nm and emission wavelength of 340 nm. Various amounts
of protein were titrated in 1.8 ml of assay buffer with 2- to 10- l
additions of NADPH of known concentration. A control titra-
tion without the enzyme in the same volume of buffer was carried
out to correct for nonenzymatic changes in the fluorescence of
NADPH. Assuming that the fluorescence quench is directly
proportional to the protein coenzyme complex, the molar frac-
tion of the protein bound at each concentration of NADPH is
given by: [E.NADPH] [E]t F Fmax, where Fmax is the
maximal fluorescence change with complete saturation, F is the
observed fluorescence change and [E]t is the total protein
concentration. Fmax can be calculated from a linear double-
reciprocal plot (1 f luorescence change versus1 [NADPH])
and the dissociation constant (Kd) is calculated from the replot
of 1 (1 ) versus [NADPH]total according to Ward s
method (19).
To confirm the NADPH binding characteristics of the fusion Fig. 1. (A C) Northern blot analyses of RSOR in kidneys of control (NM) and
protein and its immunologic cross-reactivity with other reduc- DM. RSOR is up-regulated in DM kidneys (A). The -actin expression is unaf-
tases, i.e., ALR1 and ALR2, Western blot analyses were per- fected (C). B is the same blot stained with methylene blue, and it shows
formed. In addition, NADPH binding characteristics of proteins intactness of the RNAs and their loading of equal amounts in various lanes. (D)
present in the kidney cortex were investigated. Mouse kidney Alignment of the amino acid sequences of mouse, rat, and human RSOR. Dots
cortices were homogenized in 0.1 M potassium phosphate buffer indicate the identity of the amino acids. Mouse RSOR has 97% and 91%
sequence homology with rat and human forms, respectively. Arrows indicate
containing 1 mM EDTA, pH 7.0. The extract was centrifuged at
N and C terminals of the RSOR. * indicates glycosylation site. MAKSKDSFR-
13,000 g, and the supernatant was passed through a reactive
NYTSGPL, AKR motif.
blue agarose (RBG) column (Sigma) equilibrated with the
phosphate buffer. The column was washed with the same buffer
and eluted with 1 mM NADPH in the buffer solution. The the nonmammalian proteins isolated from Arabidopsis thaliana
fractions were pooled and concentrated. Aliquots of the super- and Pinus radiata. Among the homologues that were isolated
natant of the extract, eluant, fusion protein, ALR1, ALR2, and from the cDNA libraries (Fig. 1D), it had 97% and 91%
BSA were subjected to SDS PAGE after adjusting the protein amino acid sequence homology with rat and human, respectively.
concentration. The proteins were electroblotted onto a NC In the mouse cDNA, an eukaryotic consensus polyadenylation
membrane, and Western blotting was performed as described site (AATAAA) was present at positions 142 147 downstream
above by using antifusion protein antibody. from the termination codon, suggesting that the 3 untranslated
region of the cDNA is virtually complete.
Results
Isolation and Characterization of Differentially Expressed Genes in
Northern Blot and Southern Blot Analyses. Using the mouse RSOR
Streptozotocin-Induced DM Kidney. Several DNAs that were dif-
cDNA as a probe, a single mRNA transcript of 1.5 kb was
ferentially expressed by cDNA-RDA were identified, and one of
observed in kidneys of various species (Fig. 2A). The blot stained
them (130 bp) yielded a mRNA transcript of 1.5 kb (Fig. 1A)
with methylene blue (Fig. 2C) and hybridized with -actin probe
Compared with control, its expression was up-regulated in
(Fig. 2D) indicated equal amounts of RNA loading in various
several different DM kidneys (Fig. 1 A). The amount of total
lanes; however, the hybridization signal was weak in human
RNA loaded (30 g) in each lane was comparable, and that is
kidney RNA. This weak signal may be caused by the use of the
reflected in the same blot stained with methylene blue (Fig. 1B).
mouse cDNA probe and suggested that there may be differences
The mRNA expression of -actin was similar in DM and NM
among the various species in the genomic organization of the
kidneys (Fig. 1C). Using the 130-bp DNA difference product as
RSOR. This is conceivable because the blot hybridized with
a screening probe, several clones were isolated. Two clones had
human RSOR cDNA as a probe revealed a relatively weak signal
initiation and termination codons, and they contained an ORF
in mouse kidney RNA (Fig. 2 B). Southern blot analyses yielding
of 285 aa with a predicted putative protein product of 33 kDa.
different banding pattern of the DNA digested with restriction
The structural analyses of the protein revealed multiple phos-
endonucleases confirmed that there are significant differences in
phorylation sites and an N-terminal AKR motif, MAKSKDS-
the genomic organization of the RSOR among various species
FRNYTSGPL, encompassing 21 36 amino acid residues (Fig.
(Fig. 2 E J).
1D). A single potential N-glycosylation site was present, and
interestingly, it was located within this motif. The protein had a
high aspartic acid content with a predicted pI of 4.88. In view Verification of the RSOR cDNA and Characterization of the Fusion
Protein and the Antibody. The in vitro translation revealed a
of these characteristics, the protein was tentatively designated as
translated product of 33 kDa that corresponded to the ORF of
renal-specific oxido-reductase (RSOR), although it does not
the putative protein product. Because the translated product
have any homology with other members of the AKR family.
Intriguingly, it had homologous sequences in certain segments of from two different cDNA clones had identical molecular
9898 www.pnas.org Yang et al.
Fig. 4. (A) Northern blot of RNAs from various mouse tissues hybridized with
RSOR cDNA. A 1.5-kb mRNA transcript is observed only in the kidney. The
-actin mRNA expression is similar in all of the tissues (B). (C) Western blot of
protein extracts of various tissues hybridized with antifusion protein anti-
body. A 33-kDa band is seen exclusively in the kidney.
Fig. 2. (A D) Northern blot of kidney mRNA of normal mouse, rat, and
the various tissues examined (Fig. 4A). Similarly, Western blot
human, hybridized with mouse (A) and human (B) cDNA probes. A single
analyses also indicated a single band of 33 kDa confined only
transcript of 1.5 kb is observed in all of the species (A and B). Loading of equal
to the kidney (Fig. 4C). The in situ tissue autoradiograms
amount of RNAs of various species is re ected by the similar intensity of 28S
and 18S bands in the blot stained with methylene blue (C) and by comparable revealed that it is exclusively expressed in the tubular epithelium
-actin expression (D). (E J) Southern blots of genomic DNA of mouse, rat, and
of the renal cortex whereas it is absent in the glomeruli and
human, digested with restriction endonucleases and hybridized with 5 end-
medulla (Fig. 5 A C). To further delineate its expression in
speci c (E, G, and I) and 3 end-speci c (F, H, and J) RSOR cDNA probes. The
various renal tubular segments, immunofluorescence studies
banding pro le is variable, suggesting that the genomic organization of the
BIOCHEMISTRY
were performed on serial tissue sections stained with anti-
RSOR is different among the three species.
RSOR, anti-Tamm Horsfall, and antiaquaporin-2 antibodies. A
strong intracellular immunoreactivity was seen in the tubular
weights, it suggested that the isolated cDNA has a corresponding epithelia throughout the renal cortex of the kidney (Fig. 5 D F
authentic protein (Fig. 3A). Similarly, the presence of a 35-kDa and J L). The immunoreactivity of RSOR was absent in tubular
band in SDS PAGE of the fusion proteins from two different segments exhibiting immunoreactivity for Tamm Horsfall (Fig.
clones established the authenticity of the ROSR protein (Fig. 5 G I) and aquaporin-2 (Fig. 5 M O), suggesting that the RSOR
3B). The excess 2.5-kDa mass is caused by the addition of is expressed exclusively in the renal proximal tubular epithelium.
c-myc-(His)6-tag. The detection of a single 35-kDa band by
Western blot analyses confirmed identity of the protein and Functional Characterization of the Fusion Protein. An increasing
specificity of the polyclonal antibody (Fig. 3C). The specificity of degree of fluorescence quenching was observed with the addi-
the latter is further reflected by the reduction in the intensity of tion of increasing amounts of NADPH, and it is graphically
the band when the antibody-absorbed fusion protein was sub- depicted in the titration curve (Fig. 6A). These results suggest
jected to SDS PAGE (Fig. 3C, lane 2). that the fusion protein has a high affinity NADPH binding site
or domain with KdNADPH 66.9 2.3 nM.
Tissue Expression Analyses of RSOR. Northern blot analyses re-
The Western blot analysis, using antifusion protein antibody,
vealed a single 1.5-kb mRNA transcript in the kidney among
also indicated the presence of such an NADPH binding protein
in the kidney cortex because the eluant from the RBG column
yielded a band of 33 kDa (Fig. 6B, lane 4). The immunoreac-
tivity of the band was less compared with the whole homogenate
of the kidney cortex (Fig. 6B, lane 3), although comparable
amounts of protein were loaded for SDS PAGE analyses. It is
conceivable that exact protein concentration may be difficult to
assess by the Bio-Rad protein assay in the eluant from the RBG
column because protein is still bound to the NADPH. The fusion
protein band was 35 kDa, where 2.5 kDa is caused by the
presence of c-myc-(HIS)6-tag (Fig. 6B, lane 5). No immunore-
activity with the BSA (Fig. 6B, lane 6) and negligible reactivity
Fig. 3. (A) Pro les of in vitro-translated products. Two different cDNA clones
with the recombinant ALR2 (Fig. 6B, lane 2) were observed.
yield identical 33-kDa products (lanes 2 and 3). The 61-kDa product in lane
Interestingly, a mild immunoreactivity was detected with the
1 is generated from the control plasmid. (B) SDS PAGE of fusion proteins
generated from two different constructs. Identical 35-kDa bands are seen in recombinant ALR1 (Fig. 6B, lane 1), suggesting that polyclonal
gel stained with Coomassie blue. Additional 2.5 kDa is caused by the c-myc-
antifusion antibody has some cross-reactivity with other mem-
(His)6-tag in the fusion protein. (C) Western blot analyses of the fusion protein
bers of the AKR family. By densitometric analysis, the intensity
before (lane 1) and after (lane 2) absorption with the anti-RSOR antibody. The
of the recombinant ALR1 band was 25-fold less compared with
intensity of the 35-kDa band is notably reduced after absorption, suggesting
the novel fusion protein (Fig. 6B, lane 1 vs. 5).
that the antibody is speci cally directed against the 35-kDa RSOR.
Yang et al. PNAS August 29, 2000 vol. 97 no. 18 9899
Fig. 5. Low (A), medium (B), and high (C) magni cation photomicrographs of in situ autoradiograms of kidney tissue sections hybridized with RSOR riboprobe.
The RSOR mRNA is exclusively expressed in tubules of the renal cortex and is absent in the medulla and glomeruli (arrowheads). (D F and J L) Photomicrographs
with different magni cations of the kidney sections stained with anti-RSOR antibody. The spatial protein expression of RSOR is similar to the mRNA message,
and it is absent in the medulla and glomeruli (arrowheads). (G I) Immuno uorescence photographs of kidney sections stained with anti-Tamm Horsfall protein
antibody, a marker of distal tubular epithelium (arrows). The photographs depicted in G I are the serial tissue sections of micrographs shown in D F. (M O)
Immuno uorescence photographs of kidney sections stained with anti-aquaporin-2 antibody, a marker of collecting duct epithelium (arrows). The photographs
depicted in M O are the serial tissue sections of micrographs shown in J L. Absence of RSOR immunoreactivity in the distal and collecting tubules suggests that
it is exclusively expressed in the proximal tubules. Magni cations: A, D, G, J, and M, 10; B, E, H, K, and N, 20; C, F, I, L, and O, 40.
where identical molecular weight bands were observed by using
Discussion
two different cDNA clones. Similarly, generation of identically
AKRs are a family of monomeric oxido-reductases that catalyze
sized recombinant proteins from different cDNA clones further
the NADPH-dependent reduction of a wide variety of aliphatic
supports the translatability of the isolated cDNA.
and aromatic aldehydes and ketones (11). The functions of most
Unlike the ALR1 and ALR2 that are widely distributed in
of the family members are not very well defined, nevertheless,
various tissues, the mRNA transcript of the isolated clone was
ALR1 and ALR2 have been under intense investigation (7, 10,
exclusively expressed in the kidney. Both ALR1 and ALR2 and
17, 20 25), and the latter has received the most attention
AKR-related family members have been isolated from the
because of its pathophysiologic relevance to diabetic complica-
kidney, but their sequences are nonhomologous with this renal-
tions (26). Besides, the increased amounts of glycated proteins
specific cDNA (29, 30). The Western blot, using antifusion
and sorbitol, the ALR2 activity and expression of its 1.5-kb
protein antibody, confirmed that it is exclusively expressed in the
mRNA transcript have been found to be up-regulated in kidneys
kidney. Next, intrarenal spatial distribution of this renal-specific
of diabetic rats (27, 28). Because a similar-sized mRNA tran-
gene was studied in view of the fact that ALRs also are expressed
script was found to be up-regulated in several DM kidneys, our
in the kidney (30). The ALR2 is expressed in the mesangial cells
initial considerations were that the 130-bp clone isolated by
where it is involved in the pathophysiology of the glomerulus in
cDNA-RDA is a fragment of the known mammalian ALR2.
diabetes (31), and it is also present in the medulla where it is
However, the fact that no sequence homology was observed led
believed to serve as an osmolyte regulator (32). Unlike the
us to isolate the full-length cDNA. The latter, with a putative
ALRs, both mRNA and protein expression of this novel gene
protein product of 33 kDa, also did not reveal any sequence
were confined to the cortical tubules and not in the glomeruli.
homology with AKR family members or other known mamma-
Further delineation of its expression revealed that it neither
lian sequences in the GenBank database. However, the isolated
codistributes with Tamm Horsfall protein nor with aquaporin-2,
cDNA had partial homology with proteins derived from A.
indicating that it is restricted to the proximal tubular epithelia,
thaliana and P. radiata. The fact that rat and human cDNA
and thus can be regarded as one of their specific markers. In
sequences were quite homologous and yielded similar ORFs and
addition, immunofluorescence studies suggest that it is an in-
mRNA transcripts indicated that it is likely a translatable gene.
Such a notion was supported by in vitro translational studies tracytoplasmic protein, and that is in line with its deduced
Fig. 6. (A) Titration curve depicting a high af nity of the RSOR fusion protein for NADPH. (B) SDS PAGE of various proteins analyzed by Western blot hybridized
with antifusion protein antibody. Lane 1, ALR1; lane 2, ALR2; lane 3, kidney cortex extract; lane 4, RBG column eluant of the kidney extract, lane 5, RSOR fusion
protein; lane 6, BSA. Reactivity with the eluant from RBG column (lane 4) indicates recognition of NADPH binding protein by the anti-RSOR antibody. Mild
cross-reactivity with the ALR1 also is observed (lane 1). (C) Comparison of amino acid sequence of AKR motifs. Motif sequences are boxed. The NADPH binding
sites are bolded and underscored. M-RSOR*, mouse RSOR; M-17 HSD, mouse 17 -hydroxysteroid dehydrogenase; B-PGFS, bovine lung prostaglandin F synthase;
H-BABPDD, bile acid binding protein dihydrodiol dehydrogenase; Frog-Rho, -crystallin; R-ALR1, rat ALR1; M-ALR2, mouse ALR2.
9900 www.pnas.org Yang et al.
protein sequence where no extended transmembrane hydropho- mutation of amino acids downstream of the AKR-3 motif, i.e.,
Arg311 in ALR1, and Cys298 and Cys303 in ALR2, resulted in their
bic stretches were observed.
Interestingly, a stretch of amino acids identified as AKR-3 altered catalytic properties (17, 24, 34). Such studies are deemed
signature was observed in this renal proximal tubular epithelial- necessary to determine the kinetic properties and substrate
specific protein. The fact that its molecular weight was compa- specificity of the RSOR. Initial attempts to study the kinetic
rable to most of the AKR members, i.e., 30 40 kDa, and being properties of RSOR, using traditional substrates, e.g., D-glucose
acidic, i.e., pI 4.9, suggested that it may have properties that are and DL-glyceraldehyde, were not successful. It may be that the
characteristic of this superfamily. Fluorescence quenching stud- AKR-3 motif is located near the N terminus and contains an
ies indeed indicated that it has a high affinity binding site for N-linked glycosylation site. The latter may be needed for the
NADPH with KdNADPH 67 nM. The Western blotting of the catalytic activity of RSOR, although it seems not to be essential
eluant proteins from the RBG column also attests that it is a for the activity of ALR1 or ALR2, in which the AKR-3 motif is
NADPH binding protein and can be designated as RSOR. The not glycosylated. Certainly, studies are anticipated in which
NADPH binding site is located within the AKR-3 motif, and a RSOR would be expressed in insect cells to isolate its glycosy-
comparison of this domain with other AKR members is shown lated form for the delineation of its substrate specificity, catalytic
in Fig. 6C. It is conceivable that because of the sequence domains, and kinetic properties.
similarity in AKR motif and NADPH domain a weak RSOR- In summary, a RSOR with high affinity for NADPH that is
antibody cross-reactivity with the ALR2 was observed. The up-regulated in experimental streptozotocin-induced diabetes
domain is comprised of a tetrapeptide, Ile-Pro-Lys-Ser (IPKS), mellitus is described, and the mechanism(s) by which its expres-
where the first two amino acids may be variable. The lysine sion is modulated by hyperglycemia, whether related to the
residue seems to be the critical amino acid residue because its oxidant or osmotic stress, should be the subject of further studies.
modification by pyridoxal 5 phosphate affects the catalytic Finally, because the RSOR s expression is tubular-specific, the
efficiency of ALR1 and ALR2 (21, 23). Intriguingly, the AKR-3 studies also would yield important clues as to the pathogenesis
motif in the RSOR is located near the N terminus, whereas it is of tubular lesions, which incidentally also play a major role in the
confined to the C terminus in most of the AKR members, pathogenesis of renal complications in diabetes mellitus (35).
including some of the structural proteins, e.g., -crystallin (33).
The significance of the C terminus, in terms of substrate binding This work was supported by National Institutes of Health Grants
sites of the ALRs, is emphasized by studies where substitution or DK28492 and DK36118.
1. Parving, H.-H., Osterby, R. & Ritz, E. (2000) in The Kidney, ed. Brenner, B. M. 19. Ward, L. K. (1985) Methods Enzymol. 117, 400 414.
(Saunders, Philadelphia), pp. 1731 1773. 20. Bohren, K. M., Bullock, B., Wermuth, B. & Gabbay, K. H. (1989) J. Biol. Chem.
2. Sharma, K. & Ziyadeh, F. N. (1994) Am. J. Physiol. 266, F829 F842. 264, 9547 9551.
BIOCHEMISTRY
3. Border, W. A. (1994) Curr. Opin. Nephrol. Hypertens. 3, 54 58. 21. Morjana, N. M., Lyons, C. & Flynn, T. G. (1989) J. Biol. Chem. 264, 2912 2919.
4. Khalifah, R. G., Baynes, J. W. & Hudson, B. G. (1999) Biochem. Biophys. Res. 22. Vander Jagt, D. L., Robinson, B., Kelly, K. T. & Hunsaker, L. A. (1990) J. Biol.
Commun. 257, 251 258. Chem. 265, 209**-*****.
5. Casey, E. B., Zhao, H.-R. & Abraham, E. C. (1995) J. Biol. Chem. 270, 23. Flynn, T. G., Lyons, C. & Hyndman, D. J. (1990) Adv. Enzymol. 30, 195 213.
207**-*****. 24. Bohren, K. M., Grimshaw, C. E. & Gabbay, K. H. (1992) J. Biol. Chem. 267,
6. Zhao, H.-R., Nagaraj, R. H. & Abraham, E. C. (1997) J. Biol. Chem. 272, 209**-*****.
144**-*****. 25. Liu, S. Q., Bhatnagar, A. & Srivastava, S. K. (1993) J. Biol. Chem. 268,
7. Gabbay, K. H., Merola, L. O. & Field, R. A. (1966) Science 151, 209 210. 254**-*****.
8. Bleyer, A. J., Fumo, P., Snipes, E. R., Goldfarb, S., Simmons, D. A. & Ziyadeh, 26. Fuji, J., Takahashi, M., Hamaoka, R., Kawasaki, Y., Miyazawa, N. & Taniguchi,
F. N. (1994) Kidney Int. 45, 659 666. N. (1999) Adv. Exp. Med. Biol. 463, 419 426.
9. Morrisey, K., Steadman, R., Williams, J. D. & Phillips, A. O. (1999) Kidney Int. 27. Das, B. & Srivastava, S. K. (1985) Diabetes 34, 1145 1151.
55, 160 167. 28. Ghahary, A., Luo, J., Gong, Y., Chakrabarti, S., Sima, A. A. F. & Murphy, L. J.
10. Vander Jagt, D. L., Robinson, B., Taylor, K. K. & Hunsaker, L. A. (1992) J. Biol. (1989) Diabetes 38, 1067 1071.
Chem. 267, 4364 4369. 29. Gui, T., Tanimoto, T., Kokai, Y. & Nishimura, C. (1995) Eur. J. Biochem. 277,
11. Jez, J. M., Flynn, T. G. & Penning, T. M. (1997) Biochem. Pharmacol. 54, 448 453.
639 647. 30. Robinson, B., Hunsaker, L. A., Strangebye, L. A. & Vander Jagt, D. L. (1993)
12. Wada, J. & Kanwar, Y. S. (1998) Proc. Natl. Acad. Sci. USA 95, 144 149. Biochim. Biophys. Acta 1203, 260 266.
13. Wada, J., Kumar, A., Liu, Z., Ruoslahti, E., Reichardt, L., Marvaldi, J. & 31. Kikkawa, R., Umemura, K., Haneda, M., Kajiwara, N., Naeda, S., Nishimura,
Kanwar, Y. S. (1996) J. Cell Biol. 132, 1161 1176. C. & Shigeta, Y. (1992) Diabetes 41, 1165 1171.
14. Wada, J. & Kanwar, Y. S. (1997) J. Biol. Chem. 272, 6078 6086. 32. Schwartz, G. J., Zavilowitz, B. J., Radice, A. D., Garcia-Perez, A. & Sands, J. M.
15. Venkatachalam, M. A. & Kriz, W. (1992) in Pathology of the Kidney, ed. (1992) J. Clin. Invest. 90, 1275 1283.
Heptinstall, R. H. (Little, Brown, Boston), pp. 1 90. 33. Carper, D., Nishimura, C., Shinohara, T., Dietzchold, B., Wistow, G., Craft, C.,
16. Knepper, M. A., Verbalis, J. G. & Nielson, S. (1997) Curr. Opin. Nephrol. Kador, P. & Kinoshita, J. H. (1987) FEBS Lett. 220, 209 213.
Hypertens. 6, 367 371. 34. Barski, O. A., Gabbay, K. H. & Bohren, K. M. (1996) Biochemistry 35,
17. Petrash, J. M., Harter, T. M., Devine, C. S., Olins, P. O., Bhatnagar, A., Liu, 142**-*****.
S. & Srivastava, S. K. (1992) J. Biol. Chem. 267, 248**-*****. 35. Ihm, C. G., Lee, G. S. L., Nast, C. C., Artishevsky, A., Guillermo, R., Levin,
18. Das, B. & Srivastava, S. K. (1985) Biochim. Biophys. Acta 840, 324 333. P. S., Glassock, R. J. & Adler, S. G. (1992) Kidney Int. 41, 768 777.
Yang et al. PNAS August 29, 2000 vol. 97 no. 18 9901